{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:51:11Z","timestamp":1793767871579,"version":"4.6.1"},"reference-count":31,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8,1]]},"abstract":"<jats:p>BACKGROUND. Encephalitis is a complex, debilitating, and sometimes fatal neurologic condition to which children are especially prone. Mycoplasma pneumoniae, a common respiratory pathogen, has been implicated as an etiology of encephalitis. Evidence for recent or acute M pneumoniae infection has been demonstrated in limited studies of both pediatric and adult patients with encephalitis.<\/jats:p>\n               <jats:p>PATIENTS AND METHODS. Unexplained encephalitis cases are referred to the California Encephalitis Project for diagnostic testing. Serum, cerebrospinal fluid, and respiratory specimens are tested by polymerase chain reaction and serology methods for the presence of multiple pathogens, including M pneumoniae. M pneumonia\u2013associated cases of encephalitis were compared with other bacterial agents, herpes simplex virus 1, and enterovirus.<\/jats:p>\n               <jats:p>RESULTS. Of 1988 patients referred to the California Encephalitis Project, evidence of acute M pneumoniae infection was found in 111 patients, of which 84 (76%) were pediatric patients. Eighty percent of the 84 patients were positive for M pneumoniae by serology alone. Cerebrospinal fluid polymerase chain reaction for M pneumoniae was rarely positive (2%). Patients with M pneumoniae\u2013associated pediatric encephalitis were a median of 11 years old, progressed rapidly (median: 2 days from onset to hospitalization), and were often in the ICU (55%). Symptoms included fever (70%), lethargy (68%), and altered consciousness (58%). Gastrointestinal (45%) and respiratory (44%) symptoms were less common. Compared with patients with other bacterial as well as viral agents, patients with M pneumoniae\u2013associated encephalitis had fewer seizures and less-severe hospital courses.<\/jats:p>\n               <jats:p>CONCLUSIONS. M pneumoniae is the most common agent implicated in the California Encephalitis Project. Patients with M pneumoniae\u2013associated encephalitis are predominantly pediatric, and their presentations are clinically similar to enterovirus encephalitis, although they frequently require intensive care with prolonged hospitalizations. Given that M pneumoniae infection is found more than any other pathogen, increased emphasis should be placed on elucidating the role and mechanism of M pneumoniae in encephalitis.<\/jats:p>","DOI":"10.1542\/peds.2007-0240","type":"journal-article","created":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T17:53:25Z","timestamp":1185990805000},"page":"305-313","source":"Crossref","is-referenced-by-count":129,"title":["Pediatric Encephalitis: What Is the Role of <i>Mycoplasma pneumoniae<\/i>?"],"prefix":"10.1542","volume":"120","author":[{"given":"Laura J.","family":"Christie","sequence":"first","affiliation":[{"name":"California Department of Health Services, Viral and Rickettsial Disease Laboratory, Richmond, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Honarmand","sequence":"additional","affiliation":[{"name":"California Department of Health Services, Viral and Rickettsial Disease Laboratory, Richmond, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah F.","family":"Talkington","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, National Center for Zoonotic, Vectorborne, and Enteric Diseases, Division of Foodborne, Bacterial and Mycotic Diseases, Enteric Diseases Laboratory Preparedness Branch, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa S.","family":"Gavali","sequence":"additional","affiliation":[{"name":"California Department of Health Services, Viral and Rickettsial Disease Laboratory, Richmond, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Preas","sequence":"additional","affiliation":[{"name":"California Department of Health Services, Viral and Rickettsial Disease Laboratory, Richmond, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yang","family":"Pan","sequence":"additional","affiliation":[{"name":"California Department of Health Services, Viral and Rickettsial Disease Laboratory, Richmond, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Yagi","sequence":"additional","affiliation":[{"name":"California Department of Health Services, Viral and Rickettsial Disease Laboratory, Richmond, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Glaser","sequence":"additional","affiliation":[{"name":"California Department of Health Services, Viral and Rickettsial Disease Laboratory, Richmond, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2007,8,1]]},"reference":[{"key":"2021120901514757100_R1","unstructured":"Willoughby RE. Encephalitis, meningoencephalitis, and postinfectious encephalomyelitis. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases. Philadelphia, PA: Elsevier Science; 2003:291\u2013292"},{"key":"2021120901514757100_R2","doi-asserted-by":"crossref","unstructured":"Koskiniemi M, Korppi M, Mustonen K, et al. Epidemiology of encephalitis in children: a prospective multicentre study. Eur J Pediatr.\u20081997;156:541\u2013545","DOI":"10.1007\/s004310050658"},{"key":"2021120901514757100_R3","unstructured":"Waites K, Talkington D. New developments in human diseases due to mycoplasmas. In: Blanchard A, Browning G, eds. Mycoplasmas: Molecular Biology, Pathogenicity and Strategies for Control. Norfolk, United Kingdom: Horizon Bioscience; 2005:293\u2013294"},{"key":"2021120901514757100_R4","unstructured":"Talkington DF. Mycoplasmal and ureaplasmal infections. In: Scheld WM, Whitley RJ, Marra CM, eds. Infections of the Central Nervous System. Philadelphia, PA: Lippincott, Williams & Wilkins; 2004:605\u2013611"},{"key":"2021120901514757100_R5","doi-asserted-by":"crossref","unstructured":"Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev.\u20082004;17:697\u2013728","DOI":"10.1128\/CMR.17.4.697-728.2004"},{"key":"2021120901514757100_R6","doi-asserted-by":"crossref","unstructured":"Bitnun A, Ford-Jones E, Blaser S, Richardson S. Mycoplasma pneumoniae encephalitis. Semin Pediatr Infect Dis.\u20082003;14:96\u2013107","DOI":"10.1053\/spid.2003.127226"},{"key":"2021120901514757100_R7","doi-asserted-by":"crossref","unstructured":"Candler PM, Dale RC. Cases of central nervous system complications associated with Mycoplasma pneumoniae. Pediatr Neurol.\u20082004;31:133\u2013138","DOI":"10.1016\/j.pediatrneurol.2004.02.011"},{"key":"2021120901514757100_R8","doi-asserted-by":"crossref","unstructured":"Bitnun A, Ford-Jones EL, Petric M, et al. Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis.\u20082001;32:1674\u20131684","DOI":"10.1086\/320748"},{"key":"2021120901514757100_R9","doi-asserted-by":"crossref","unstructured":"Kolski H, Ford-Jones EL, Richardson S, et al. Etiology of acute childhood encephalitis at the Hospital for Sick Children, Toronto, 1994\u20131995. Clin Infect Dis.\u20081998;26:398\u2013409","DOI":"10.1086\/516301"},{"key":"2021120901514757100_R10","unstructured":"California Emerging Infections Program, California Encephalitis Project, Enhanced Diagnostic Testing and Epidemiology. Available at: www.ceip.us\/encephalitis.htm. Accessed December 12, 2006"},{"key":"2021120901514757100_R11","doi-asserted-by":"crossref","unstructured":"Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis.\u20082006;43:1565\u20131577","DOI":"10.1086\/509330"},{"key":"2021120901514757100_R12","unstructured":"Meridian ImmunoCard Mycoplasma [package insert]. Cincinnati, OH: Meridian Bioscience, Inc; 2002"},{"key":"2021120901514757100_R13","doi-asserted-by":"crossref","unstructured":"Cremer NE, Cossen CK, Shell G, Diggs J, Gallo D, Schmidt NJ. Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infections with those viruses. J Clin Microbiol.\u20081985;21:869\u2013874","DOI":"10.1128\/jcm.21.6.869-874.1985"},{"key":"2021120901514757100_R14","unstructured":"Association of Public Health Laboratories. Real-time (TaqMan) PCR for respiratory bacterial pathogens. Available at: www.aphl.org. Accessed January 10, 2007"},{"key":"2021120901514757100_R15","unstructured":"Schnurr D, Yagi S, Devlin R, Mohle-Boetani J, Dondero M. IgA and IgM ELISA for the study of an echovirus 30 outbreak in California. Presented at: Tenth Annual Clinical Virology Symposium; April 24, 1994; Clearwater, FL"},{"key":"2021120901514757100_R16","doi-asserted-by":"crossref","unstructured":"Nir-Paz R, Michael-Gayego A, Ron M, Block C. Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection. Clin Microbiol Infect.\u20082006;12:672\u2013694","DOI":"10.1111\/j.1469-0691.2006.01469.x"},{"key":"2021120901514757100_R17","unstructured":"Weiner LB, McMillan JA. Mycoplasma pneumoniae. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases. Philadelphia, PA: Elsevier Science; 2003:1006"},{"key":"2021120901514757100_R18","doi-asserted-by":"crossref","unstructured":"Daxboeck F, Krause R, Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect.\u20082003;9:263\u2013273","DOI":"10.1046\/j.1469-0691.2003.00590.x"},{"key":"2021120901514757100_R19","doi-asserted-by":"crossref","unstructured":"Daxboeck F, Blacky A, Seidl R, Krause R, Assadian O. Diagnosis, treatment and prognosis of Mycoplasma pneumoniae childhood encephalitis: systematic review of 58 cases. J Child Neurol.\u20082004;19:865\u2013871","DOI":"10.1177\/08830738040190110401"},{"key":"2021120901514757100_R20","doi-asserted-by":"crossref","unstructured":"Guleria R, Nisar N, Chawla TC, Biswas NR. Mycoplasma pneumoniae and central nervous system complications: a review. J Lab Clin Med.\u20082005;146:55\u201363","DOI":"10.1016\/j.lab.2005.04.006"},{"key":"2021120901514757100_R21","doi-asserted-by":"crossref","unstructured":"Granstrom M, Holme T, Sjogren AM, Ortqvist A, Kalin M. The role of IgA determination by ELISA in the early serodiagnosis of Mycoplasma pneumoniae infection, in relation to IgG and \u03bc-capture IgM methods. J Med Microbiol.\u20081994;40:288\u2013292","DOI":"10.1099\/00222615-40-4-288"},{"key":"2021120901514757100_R22","doi-asserted-by":"crossref","unstructured":"Nishimura M, Saida T, Kuroki S, et al. Post-infectious encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection. J Neurol Sci.\u20081996;140:91\u201395","DOI":"10.1016\/0022-510X(96)00106-2"},{"key":"2021120901514757100_R23","doi-asserted-by":"crossref","unstructured":"Fernandez CV, Bortolussi R, Gordon K, Lee SHS, Gatien JG, Shahdrabadi MS. Mycoplasma pneumoniae infection associated with central nervous system complications. J Child Neurol.\u20081993;8:27\u201331","DOI":"10.1177\/088307389300800104"},{"key":"2021120901514757100_R24","doi-asserted-by":"crossref","unstructured":"Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci U S A.\u20082006;103:6724\u20136729","DOI":"10.1073\/pnas.0510644103"},{"key":"2021120901514757100_R25","doi-asserted-by":"crossref","unstructured":"Kusonoki S, Shiina M, Kanazawa I. Anti-Gal-C antibodies in GBS subsequent to Mycoplasma infection: evidence of molecular mimicry. Neurology.\u20082001;57:736\u2013738","DOI":"10.1212\/WNL.57.4.736"},{"key":"2021120901514757100_R26","doi-asserted-by":"crossref","unstructured":"Susuki K, Odaka M, Mori M, Hirata K, Yuki N. Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry. Neurology.\u20082004;62:949\u2013956","DOI":"10.1212\/01.WNL.0000115123.42929.FD"},{"key":"2021120901514757100_R27","doi-asserted-by":"crossref","unstructured":"Sakoulas G. Brainstem and striatal encephalitis complicated Mycoplasma pneumoniae pneumonia: possible benefit of intravenous immunoglobulin. Pediatr Infect Dis J.\u20082001;20:543\u2013545","DOI":"10.1097\/00006454-200105000-00016"},{"key":"2021120901514757100_R28","doi-asserted-by":"crossref","unstructured":"Azimi PH, Chase PA, Petru AM. Mycoplasmas: their role in pediatric disease. Curr Probl Pediatr.\u20081984;14:1\u201346","DOI":"10.1016\/0045-9380(84)90019-7"},{"key":"2021120901514757100_R29","doi-asserted-by":"crossref","unstructured":"Murray HW, Masur H, Senterfit LB, Roberts RB. The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med.\u20081975;58:229\u2013242","DOI":"10.1016\/0002-9343(75)90574-4"},{"key":"2021120901514757100_R30","doi-asserted-by":"crossref","unstructured":"Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998\u20132000. Clin Infect Dis.\u20082003;36:731\u2013742","DOI":"10.1086\/367841"},{"key":"2021120901514757100_R31","doi-asserted-by":"crossref","unstructured":"Lewis P, Glaser CA. Encephalitis. Pediatr Rev.\u20082005;26:353\u2013363","DOI":"10.1542\/pir.26-10-353"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/2\/305\/1119909\/zpe00807000305.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/2\/305\/1119909\/zpe00807000305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T07:57:31Z","timestamp":1639036651000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/120\/2\/305\/70385\/Pediatric-Encephalitis-What-Is-the-Role-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,8,1]]},"published-print":{"date-parts":[[2007,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-0240","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,1]]}}}